Literature DB >> 29021840

Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Maria Vadalà1,2, Dimitri Poddighe3, Carmen Laurino1,2, Beniamino Palmieri1,2.   

Abstract

Autoimmune diseases, including multiple sclerosis and type 1 diabetes mellitus, affect about 5% of the worldwide population. In the last decade, reports have accumulated on various autoimmune disorders, such as idiopathic thrombocytopenia purpura, myopericarditis, primary ovarian failure, and systemic lupus erythematosus (SLE), following vaccination. In this review, we discuss the possible underlying mechanisms of autoimmune reactions following vaccinations and review cases of autoimmune diseases that have been correlated with vaccination. Molecular mimicry and bystander activation are reported as possible mechanisms by which vaccines can cause autoimmune reactions. The individuals who might be susceptible to develop these reactions could be especially not only those with previous post-vaccination phenomena and those with allergies but also in individuals who are prone to develop autoimmune diseases, such as those with a family history of autoimmunity or with known autoantibodies, and the genetic predisposed individuals. Further research is encouraged into the direct associations between vaccines and autoimmune conditions, and the biological mechanisms behind them.

Entities:  

Keywords:  Diabetes; Genetic test; Individualized patient profile; Multiple sclerosis; Predictive preventive personalized medicine; Vaccine

Year:  2017        PMID: 29021840      PMCID: PMC5607155          DOI: 10.1007/s13167-017-0101-y

Source DB:  PubMed          Journal:  EPMA J        ISSN: 1878-5077            Impact factor:   6.543


  150 in total

1.  Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history.

Authors:  Glinda S Cooper; Mary Anne Dooley; Edward L Treadwell; E William St Clair; Gary S Gilkeson
Journal:  J Clin Epidemiol       Date:  2002-10       Impact factor: 6.437

2.  [Sclerotic plaques and vaccination against hepatitis B].

Authors:  O Gout; O Lyon-Caen
Journal:  Rev Neurol (Paris)       Date:  1998-04       Impact factor: 2.607

3.  Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins.

Authors:  H Peltola; O P Heinonen
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

4.  Vaccinations and risk of central nervous system demyelinating diseases in adults.

Authors:  Frank DeStefano; Thomas Verstraeten; Lisa A Jackson; Catherine A Okoro; Patti Benson; Steven B Black; Henry R Shinefield; John P Mullooly; William Likosky; Robert T Chen
Journal:  Arch Neurol       Date:  2003-04

5.  Detection of platelet-binding anti-measles and anti-rubella virus IgG antibodies in infants with vaccine-induced thrombocytopenic purpura.

Authors:  Naho Okazaki; Masahiro Takeguchi; Kohji Sonoda; Yohsuke Handa; Tatsuo Kakiuchi; Hiroaki Miyahara; Kensuke Akiyoshi; Seigo Korematsu; Soichi Suenobu; Tatsuro Izumi
Journal:  Vaccine       Date:  2011-05-01       Impact factor: 3.641

6.  Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients.

Authors:  U Nieminen; H Peltola; M T Syrjälä; A Mäkipernaa; R Kekomäki
Journal:  Acta Paediatr       Date:  1993-03       Impact factor: 2.299

7.  Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.

Authors:  M N Hocine; C P Farrington; E Touzé; H J Whitaker; A Fourrier; T Moreau; P Tubert-Bitter
Journal:  Vaccine       Date:  2007-06-08       Impact factor: 3.641

8.  The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

Authors:  T Lasky; G J Terracciano; L Magder; C L Koski; M Ballesteros; D Nash; S Clark; P Haber; P D Stolley; L B Schonberger; R T Chen
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

9.  Lambert-Eaton myasthenic syndrome following H1N1-influenza vaccination: a case report.

Authors:  Hanna Ansakorpi; Harri Rusanen; Seppo Rytky; Markus Färkkilä
Journal:  Acta Neurol Scand       Date:  2012-05-10       Impact factor: 3.209

10.  Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.

Authors:  Amy S McKee; Michael W Munks; Megan K L MacLeod; Courtney J Fleenor; Nico Van Rooijen; John W Kappler; Philippa Marrack
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

View more
  36 in total

1.  Neuromyelitis optica associated with yellow fever vaccination.

Authors:  Bruno Bertoli Esmanhotto; Isabella Moraes Rocha; Carolina Rodrigues Laranjeira Vilar; Rafael Follador Haluch; Thaís Pimenta Valença
Journal:  Acta Neurol Belg       Date:  2020-06-10       Impact factor: 2.396

2.  Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.

Authors:  Yuleima Diaz; Morten L Govasli; Ephrem Debebe Zegeye; Halvor Sommerfelt; Hans Steinsland; Pål Puntervoll
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

3.  A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination.

Authors:  Beop Chang Kim; Han Seong Kim; Kum Hyun Han; Sang Youb Han; Hyung Ah Jo
Journal:  J Korean Med Sci       Date:  2022-07-04       Impact factor: 5.354

4.  Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: A case report.

Authors:  Min Chae Kang; Kyung-Ah Park; Ju-Hong Min; Sei Yeul Oh
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-25

Review 5.  Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

Authors:  Nina Butkovich; Enya Li; Aaron Ramirez; Amanda M Burkhardt; Szu-Wen Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-08

Review 6.  Uveitis as a Predictor of Predisposition to Autoimmunity.

Authors:  Jillian A Leibowitz; Arden T Woods; Marc M Kesselman; Bindu S Mayi
Journal:  Cureus       Date:  2020-03-28

7.  A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool.

Authors:  German Todorov; Vladimir N Uversky
Journal:  Biomolecules       Date:  2020-10-14

Review 8.  Current and prospective computational approaches and challenges for developing COVID-19 vaccines.

Authors:  Woochang Hwang; Winnie Lei; Nicholas M Katritsis; Méabh MacMahon; Kathryn Chapman; Namshik Han
Journal:  Adv Drug Deliv Rev       Date:  2021-02-06       Impact factor: 17.873

Review 9.  SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis.

Authors:  Tsvetelina Velikova; Tsvetoslav Georgiev
Journal:  Rheumatol Int       Date:  2021-01-30       Impact factor: 3.580

Review 10.  Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.

Authors:  Ronald N Kostoff; Darja Kanduc; Alan L Porter; Yehuda Shoenfeld; Daniela Calina; Michael B Briggs; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Toxicol Rep       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.